US Abandons Pandemic Containment for Vaccine and Therapy Strategy
The White House admits it is not trying to control the COVID-19 pandemic, shifting focus entirely to vaccines and therapeutics as infections peak again.
The White House officially admits it is not going to control the COVID-19 pandemic, marking a significant shift away from containment and mitigation efforts. Chief of Staff Mark Meadows states that the administration focuses solely on securing vaccines, therapeutics, and other mitigation factors rather than attempting to stop the spread of the contagious virus.
This admission effectively ends hopes for a coordinated national response involving widespread testing or contact tracing through partnerships with technology companies like Apple and Google. The pivot away from active containment comes at a critical time, as the United States experiences a dangerous second peak in infection rates with over 8.1 million confirmed cases and more than 220,000 deaths.
The administration now pins all its hopes on medical interventions, specifically the vaccines and treatments currently moving through regulatory approval processes. Several American companies, including Novavax, Johnson & Johnson, Moderna Therapeutics, and Pfizer, are conducting large-scale phase-three clinical trials, recruiting tens of thousands of volunteers across the US and UK to test their potential vaccines.